Related Experiment Video

Updated: Oct 11, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Monoclonal antibodies (MAb) in clinical oncology

K Bosslet, H H Sedlacek

    Behring Institute Mitteilungen
    |June 1, 1986
    PubMed

    Insights

    Monoclonal antibodies (MAbs) are established in diagnostics and show promise in nuclear medicine imaging. Clinical trials indicate MAbs are potent for tumor therapy and drug conjugates may offer significant therapeutic effects.

    Area of Science:

    • Oncology
    • Immunology
    • Nuclear Medicine

    Background:

    • Monoclonal antibodies (MAbs) have a proven track record in serum and immunohistochemical diagnostics.
    • The application of MAbs in immunoscintigraphy is currently under evaluation for routine nuclear medicine use.

    Purpose of the Study:

    • To evaluate the current and emerging clinical applications of monoclonal antibodies (MAbs).
    • To highlight the potential of MAbs in diagnostics, imaging, and therapy of tumors.

    Main Methods:

    • Review of established diagnostic roles of MAbs.
    • Assessment of ongoing evaluations for immunoscintigraphy applications.
    • Analysis of preliminary clinical trial data for MAb-based tumor therapy.

    Main Results:

    • Monoclonal antibodies (MAbs) are clinically validated for serum and immunohistochemical diagnostics.
    • Immunoscintigraphy with MAbs is progressing towards routine nuclear medicine integration.
    • Early clinical trials demonstrate the efficacy of MAbs in treating specific tumors.

    Conclusions:

    • Monoclonal antibodies (MAbs) are expanding from diagnostics to advanced nuclear medicine applications.
    • MAbs show significant therapeutic potential for various cancers, with ongoing research into drug conjugates.

    More Related Videos

    In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

    In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

    Published on: September 16, 2019

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

    Published on: May 16, 2020

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.